BFF
ABBV icon

Byrne Financial Freedom’s AbbVie ABBV Stock Holding History

Byrne Financial Freedom’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$334K Buy
1,327
+20
+2% +$4.3K 0.13% 90
2026
Q1 		$284K Sell
1,307
-45
-3% -$9.98K 0.14% 88
2025
Q4 		$309K Buy
1,352
+15
+1% +$3.42K 0.14% 84
2025
Q3 		$310K Sell
1,337
-650
-33% -$132K 0.15% 77
2025
Q2 		$369K Sell
1,987
-13
-0.7% -$2.42K 0.18% 68
2025
Q1 		$419K Buy
2,000
+100
+5% +$19.4K 0.24% 57
2024
Q4 		$338K Buy
+1,900
New +$349K 0.15% 73

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Byrne Financial Freedom's ABBV Position: Q2 2026 in Review

Byrne Financial Freedom increased its AbbVie (ABBV) stake by 1.5% in Q2 2026, buying an estimated $4.3K and bringing the position to 1,327 shares worth $334K. The position accounts for 0.13% of the portfolio, ranked #90.

Byrne Financial Freedom first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. The position peaked at $419K in Q1 2025. 4,219 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Byrne Financial Freedom held 1,327 shares of AbbVie worth $334K as of Q2 2026.
  • Byrne Financial Freedom bought 20 AbbVie shares in Q2 2026, an estimated $4.3K.
  • AbbVie made up 0.13% of Byrne Financial Freedom's portfolio in Q2 2026, its #90 holding.
  • Byrne Financial Freedom first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • Byrne Financial Freedom's AbbVie position peaked at $419K in Q1 2025.
  • 4,219 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Byrne Financial Freedom's 13F filing for Q2 2026, filed 30 Jul 2026.